The global RTU cartridges market is projected to generate USD 294.05 million revenue by 2030, advancing at a CAGR of 8.7% during 2021–2030. This can be attributed to the high-quality operations with RTU cartridges and the increasing prevalence of diabetes.
The demand for parenteral medications is increasing due to the rising incidence of diabetes, which, in turn, is boosting the demand for RTU cartridges. According to the International Diabetes Federation (IDF), around 537 million adults had diabetes and the disease caused 6.7 million deaths in 2021. Patients can use such systems at their homes, which makes them a feasible and economical method of insulin delivery. It helps patients receive safe and accurate dosing. Such systems also have various other advantages, such as reduced error rate, fewer chances of patient harm, low risk of contamination, and decreased wastage.
Due to the COVID-19 pandemic, the major burden fell on the healthcare sector and related infrastructure, even in the most-developed countries with advanced healthcare systems. The pandemic affected the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruptions, and by having a negative financial impact on firms across markets. Moreover, manufacturing facilities remained shut during the pandemic, due to which such cartridges were not produced. This led to a mismatch between supply and demand, as the need for RTU vials increased for vaccinating people.
The nest and tube category held a larger revenue share, of 89.1%, in 2022. This is mainly attributed to the wide adoption of this packaging type among pharmaceutical companies, as it had emerged before its tray counterpart. Moreover, it prevents scratches and breakage due to its nest-like arrangement, as a result, lowering the rejection rate.
Europe held the largest revenue share, of 55.3%, in 2022. This is mainly due to the rising production capacity of vial manufacturers, the increasing healthcare expenditure, and the growing pharmaceutical industry in the region. In Europe, Germany holds the largest market share. This is attributed to the existence of key players in the country, and these companies also expand their portfolios with nested cartridges.
For instance, SCHOTT planned to significantly expand its production capacity of RTU cartridges in 2022. With the use of wearable devices or pen injectors, this drug containment and delivery method is used to store and dispense medications. The business supplies these washed, siliconized, crimped, and pre-sterilized cartridges in a nest/tub or tray arrangement. As a result, pharmaceutical companies are able to begin the drug-filling procedure right away without having to handle washing, siliconization, or sterilization themselves. The company is offering a solution for medications, which are often self-administered at home, with this expansion. This is also acknowledged as a significant commercial trend.
The major players operating in the RTU cartridges market are SCHOTT Pharma AG & Co. KGaA, Stevanato Group S.p.A, and Pharmaceutics International Inc.